2021
DOI: 10.1016/j.ejmech.2020.113112
|View full text |Cite
|
Sign up to set email alerts
|

2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 44 publications
0
11
0
Order By: Relevance
“…MAO inhibition assay was performed as previously described [ 51 ]. Supplementary Materials provides details of this assay.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…MAO inhibition assay was performed as previously described [ 51 ]. Supplementary Materials provides details of this assay.…”
Section: Methodsmentioning
confidence: 99%
“…The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetraziolium bromide (Sigma–Aldrich) reduction assay was used for measurement of the compounds’ cytotoxicity, according to Mosmann [ 51 ]. MTT is a water-soluble tetrazolium salt that is converted to purple formazan by succinate dehydrogenase in mitochondria of viable cells [ 52 , 53 ].…”
Section: Methodsmentioning
confidence: 99%
“…Naphthoquinone is one of the most studied pharmacophore groups in medicinal chemistry and it is known to be present in the molecular structure of many natural and synthetic bioactive compounds. [1][2][3] Compounds containing naphthoquinone moiety exhibit a wide range of pharmacological activities such as anti-inflammatory, [4,5] antimicrobial, [6][7][8] antiviral, [9] antimalarial, [10] and anticancer [11,12] as well as DNA cleavage activity. [13] In recent years, studies have been conducted in which various naphthoquinone derivatives have been synthesized for the treatment of Alzheimer's, and their activities on enzymes associated with this disease have been investigated.…”
Section: Introductionmentioning
confidence: 99%
“…Propargylamine is the key intermediates in several kinds of chemicals and biologically active molecules such as Parkinson's disease. [1][2][3] Different propargylamines are usually synthesized by the three-component coupling method (A 3 coupling) of amine, alkyne and aldehyde. [4][5][6][7][8][9][10][11][12][13][14] In AHA coupling reactions, halomethane is an inexpensive and readily available industrial solvent as a methylene fragment for replacing aldehydes.…”
Section: Introductionmentioning
confidence: 99%
“…Propargylamine is the key intermediates in several kinds of chemicals and biologically active molecules such as Parkinson's disease [1–3] . Different propargylamines are usually synthesized by the three‐component coupling method (A 3 coupling) of amine, alkyne and aldehyde [4–14] .…”
Section: Introductionmentioning
confidence: 99%